ArticleLung Cancer (Auckland, N.Z.)2026

Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer.

Qin Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.